Innovation and the Opioid Crisis

A $40B+ industry in the US alone. Big Fines for Big Pharma, emerging policy and new  “Addiction Tech” on a mission to change the paradigm for the treatment of pain.


The treatment of drug, alcohol and other substance addictions in the US alone is estimated to be a $40B+ industry that is being targeted by a range of tech innovators looking to disrupt a sector struggling to cope with the spiraling opioid crisis.

Digital health firms are adopting a variety of business models to shake up this relatively unreformed market, including; telehealth, remote prescribing, digital cognitive behavior therapy, peer support networks and audiovisual sensory treatments. In the 12 months to April 2021 deaths from drug overdoses passed 100k in the US, a 28.5% increase on the same period the year before.

Customers can read the full analyst note on-platform. Not a customer yet? Request a demo of HolonIQ’s market intelligence platform.

Where is this data coming from?

HolonIQ is the world's leading impact intelligence platform. We support governments, institutions, firms and investors, with data insights to power decisions that matter. If you are not already a client, request a demo to learn more about our platform.
Complex abstract graph background

Related Research

Healthcare Megarounds: 2022 activity dominated by Biotech

21 May 2022. 

66 healthcare funding rounds in excess of $100M, totalling $11.7B in ‘megarounds’ despite a rapidly cooling market

2021 North America HealthTech 200. Where are they now?

20 May 2022. 

How are North America Top 200 HealthTech Startups of 2021 performing and where are they now?

4 webinars to explore disruptive innovation in digital health

19 May 2022. 

Join HolonIQ’s Health Intelligence Unit in a series of webinars focused on the fast-moving world of digital health.

The Complete List of Global Impact Unicorns

8 May 2022. 

The Complete List of Global Impact Unicorns